Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up.

Source:http://linkedlifedata.com/resource/pubmed/id/12592331

Download in:

View as

General Info

PMID
12592331